Cooper Companies (COO) Cash from Financing Activities (2009 - 2026)
Cooper Companies (COO) posted quarterly Cash from Financing Activities of -$75.8 million for Q2 2026, down 781.4% year-over-year from $11.1 million in Q2 2025, and up 48.75% quarter-over-quarter from -$147.9 million in Q1 2026.
Cooper Companies (COO) Cash from Financing Activities (2009 - 2026) Analysis & Trends
Cooper Companies' Cash from Financing Activities history runs 18 years deep, the most recent figure standing at -$75.8 million for Q2 2026.
- In Q2 2026, Cash from Financing Activities fell 781.4% year-over-year to -$75.8 million; the TTM figure through Apr 2026 stood at -$544.4 million (down 146.11% YoY), while the FY2025 annual figure was -$425.9 million, down 1186.48% from the prior year.
- Cash from Financing Activities for Q2 2026 stood at -$75.8 million, up from -$147.9 million in the prior quarter.
- The five-year high for Cash from Financing Activities was $1.7 billion in Q1 2022, with the low at -$368.7 million in Q3 2022.
- The 5-year median for Cash from Financing Activities is -$66.4 million (2024), against an average of $22.7 million.
- The sharpest annual moves came in 2022 and 2023: Cash from Financing Activities soared 12552.94% in 2022, then plunged 1713.79% in 2023.
- Cooper Companies' Cash from Financing Activities stood at -$134.1 million in 2022, then surged by 95.15% to -$6.5 million in 2023, then slumped by 336.92% to -$28.4 million in 2024, then tumbled by 478.87% to -$164.4 million in 2025, then jumped by 53.89% to -$75.8 million in 2026.
- Business Quant data shows COO's Cash from Financing Activities at -$75.8 million in Q2 2026, -$147.9 million in Q1 2026, and -$164.4 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -287.90 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -577.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -510.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -263.16 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -159.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -164.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -300.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -75.80 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -31.00 Mn |
| 10 | Align Technology | 11.61 Bn | 10.51 Bn | 757.43 Mn | -67.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -75.80 Mn |
| Apr 30, 2026 | -75.80 Mn |
| Jan 31, 2026 | -147.90 Mn |
| Jan 31, 2026 | -147.90 Mn |
| Oct 31, 2025 | -164.40 Mn |
| Oct 31, 2025 | -164.40 Mn |
| Jul 31, 2025 | -156.30 Mn |
| Jul 31, 2025 | -156.30 Mn |
| Apr 30, 2025 | -8.60 Mn |
| Apr 30, 2025 | -8.60 Mn |
| Jan 31, 2025 | -96.60 Mn |
| Jan 31, 2025 | -96.60 Mn |
| Oct 31, 2024 | -28.40 Mn |
| Oct 31, 2024 | -28.40 Mn |
| Jul 31, 2024 | -87.60 Mn |
| Jul 31, 2024 | -87.60 Mn |
| Apr 30, 2024 | -57.10 Mn |
| Apr 30, 2024 | -57.10 Mn |
| Jan 31, 2024 | 212.30 Mn |
| Jan 31, 2024 | 212.30 Mn |